A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

NCT06283303 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

BIOLOGICAL: T3011 hepatic artery infusion
DRUG: toripalimab
DRUG: regorafenib

Sponsor

China Medical University, China

Collaborators

[object Object]